TrkB-Fc treatment was found to block this stroke-induced effect, with TrkB-Fc-treated aged stroke animals requiring significantly more consecutive days (p = 0.0222) and correction trials (p = 0.0029) to reach the criterion relative to aged stroke control animals. Here, NTRK2 is linked to Stroke.